Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MERIDIAN BIOSCIENCE INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-02-01 to 2023-01-31
Current total value of award: $8005000
Description: RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROJECT #6139: REVOGENE SARS-COV-2 ASSAY